Nanotechnology Conference and Trade Show - Nanotech 2006
> Program > Technical Conferences > Business & Development > Nano Impact Workshop > Nanotech Job Fair > Expo
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Confirmed Speakers
Conferences & Symposia

Conference Proceedings

Conference Technical Proceedings
Nanotech 2006 - Nanotechnology Conference
Gregory J. Downing

Gregory J. Downing

National Cancer Institute (NCI), US

Dr. Downing is Director of the Office of Technology and Industrial Relations (OTIR) in the Office of the Director at the National Cancer Institute (NCI), National Institutes of Health. In this role, he facilitates the collaboration among Federal, academic, and private biomedical research sectors to support technology development that will yield innovative diagnostic, detection, and targeted treatment strategies for cancer. Through the OTIR, he supervises the administration of grants and contracts for programs in nanotechnology, biosensors, therapeutic delivery systems, and new technology platforms and imaging systems. He currently serves on several committees, including the NCI-FDA Interagency Oncology Task Force and the Biomedical Information Science and Technology Consortium.

Dr. Downing began his career at the NIH in 1994 as a fellow at the National Institute for Child Health and Human Development, and subsequently served in the Office of Science Policy and Planning as a health science policy analyst and deputy director. Today, he continues to lead the implementation of training and programs that support the research policy goals of the NIH.

Dr. Downing earned his medical degree from Michigan State University and his Ph.D. in pharmacology from the University of Kansas. He completed his residency in pediatrics and fellowship in neonatology before joining the faculty of the University of Missouri-Kansas City in the Department of Neonatology at The Children’s Mercy Hospital.

Dr. Downing is certified by the American Board of Pediatrics in pediatrics and neonatology— perinatal medicine. He sits on the editorial board of the Journal of Maternal-Fetal Investigation and is Associate Editor of Disease Biomarkers. He has published numerous articles and research in the fields of pharmacology and medicine and has contributed to three books.


View Confimed Speakers

Back to Conferences & Symposia

 
Nanotechnology Conference | Terms of use | Privacy policy | Contact | NSTI Home
Program | Technical Conferences | Business & Development | Nano Impact Workshop | Nanotech Job Fair | Expo |
Nanotech 2006 Home | Press Room | Venue | Subscribe | Site Map
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.